Thomas A. Collet

Overview

Thomas A. Collet helps companies in the life science and medical industries develop and commercialize new products, technologies, and services. A former Engagement Manager for McKinsey and VP of Business Development for Monsanto, Thomas has broad, practical experience in life science, with focus on biotech, pharma and performance chemicals. His consulting practice focuses on creating strategically sound, executable business plans in uncertain, high-risk situations; he brings implementation insights to strategy projects and strategic insights to implementation projects.

Thomas has written for the BTG blog about implementing new strategies while managing ongoing priorities. He also wrote a longer guide to digitization in the life science industry and helped develop an interactive game about the serious business of updating business strategies.

Expertise

• Business plan development
• Corporate and business unit strategy
• Strategic planning
• Market landscape assessment
• Product development and launch
• Product management
• Project Management Office (PMO)

Experience

• Co-founder and CEO – Phrixus Pharmaceuticals
• Co-founder and CEO – Neural Intervention Technologies
• CEO – Rubicon Genomics
• VP – Tullis Dickerson
• VP, Business Development – Monsanto
• Engagement Manager – McKinsey

Education

• PhD (Biochemistry), MIT
• BSc (Chemistry), RWTH Aachen in Germany